검색어: multicenter (영어 - 슬로베니아어)

single center multicenter study
večcentr. raz

the efficacy of infliximab was assessed in two multicenter, randomised, double blind studies:
psoriaza učinkovitost infliksimaba so ocenjevali v dveh multicentričnih, randomiziranih, dvojno slepih študijah:

most of the primary immunogenicity studies were conducted as randomized, controlled, multicenter, clinical trials.
večina primarnih študij imunogenosti je bila opravljenih v obliki randomiziranih, kontroliranih, multicentričnih kliničnih preskušanj.

study 2 was a randomized, controlled, multicenter study comparing the zevalin therapeutic regimen versus treatment with rituximab.
druga študija je bila randomizirana, kontrolirana, multicentrična študija, v kateri so terapevtsko shemo zdravljenja z zdravilom zevalin primerjali z zdravljenjem z rituksimabom.

the immunogenicity of prevenar has been investigated in an open-label, multicenter study in 49 infants with sickle cell disease.
imunogenost cepiva prevenar so raziskali v odprti multicentrični študiji pri 49 dojenčkih z anemijo srpastih celic.

paediatric patients the safety and efficacy of cancidas was evaluated in paediatric patients 3 months to 17 years of age in two prospective, multicenter clinical trials.
pediatrični bolniki varnost in učinkovitost zdravila cancidas so pri pediatričnih bolnikih, starih od 3 mesece do 17 let, ocenili v dveh prospektivnih, multicentričnih kliničnih preskušanjih.

the efficacy of infliximab was assessed in two multicenter, randomised, double-blind studies: spirit and express.
učinkovitost infliksimaba so ocenjevali v dveh multicentričnih, randomiziranih, dvojno slepih študijah: spirit in express.

start was a randomised, multicenter, double-blind, 3-arm, parallel-group safety study.
Študija start je bila randomizirana, multicentrična, dvojno slepa študija varnosti zdravila pri vzporednih skupinah in je imela tri krake.

in this randomized, double- blind, multicenter, controlled clinical trial, ivus was performed at baseline and at 18 months in 502 patients.
rezultati raziskav in vitro kažejo, da gemfibrozil zavira presnovo atorvastatina z glukuronidacijo.

voriconazole was compared to itraconazole as primary prophylaxis in an open-label, comparative, multicenter study of adult and adolescent allogeneic hsct recipients without prior proven or probable ifi.
v odprti primerjalni multicentrični študiji so primerjali vorikonazol in itrakonazol kot primarno profilakso pri odraslih in mladostnikih, ki so bili prejemniki homolognih hsct brez predhodno dokazane ali verjetne igo.

impaact p1066 is a phase i/ii open label multicenter trial to evaluate the pharmacokinetic profile, safety, tolerability, and efficacy of raltegravir in hiv infected children.
raltegravir je dosegel virološke odzive (z uporabo metode nedokončanje = neuspeh)

an international, multicenter, randomized, open-label, comparative phase 3 efficacy and safety study was conducted in newly diagnosed ph+ cp cml patients.
izvedli so mednarodno, multicentrično, randomizirano, odprto, primerjalno študijo 3. faze pri bolnikih z novo odkrito ph+ kml v kronični fazi, v kateri so ocenjevali učinkovitost in varnost.

in two multicenter, randomized, double-blind, placebo-controlled pivotal studies 234 subjects with a recent history of frequent heartburn were treated with 20 mg esomeprazole for 4 weeks.
v dveh multicentričnih, randomiziranih, dvojno slepih, s placebom kontroliranih ključnih študijah je 234 preiskovancev z nedavno anamnezo pogoste zgage 4 tedne prejemalo 20 mg esomeprazola.

results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens urology 2002; 59:
results from a randomized, double- blind, multicenter trial comparing single- dose to 3- day fluoroquinolone regimens urology 2002; 59: